# Tofacitinib in Juvenile Idiopathic Arthritis

> **NCT07211932** · — · NOT_YET_RECRUITING · sponsor: **Consorci Sanitari de l'Alt Penedès i Garraf** · enrollment: 58 (estimated)

## Conditions studied

- Juvenile Idiopathic Arthritis (JIA)

## Interventions

- **DRUG:** Tofacitinib

## Key facts

- **NCT ID:** NCT07211932
- **Lead sponsor:** Consorci Sanitari de l'Alt Penedès i Garraf
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2025-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07211932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07211932, "Tofacitinib in Juvenile Idiopathic Arthritis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07211932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*